黄瓜视频app

News

company

year

domain

Repertoire庐 Immune Medicines Enters into Collaboration and License Agreement with Genentech for the Development of T cell-Targeted Therapies for an Autoimmune Disease

Repertoire庐 Immune Medicines 04.23.2025

Repertoire庐 Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases

Repertoire庐 Immune Medicines 04.29.2024

Loading